首页|加味来复汤对慢性心力衰竭急性加重期血清H-FABP、cTnⅠ及NT-proBNP表达的影响

加味来复汤对慢性心力衰竭急性加重期血清H-FABP、cTnⅠ及NT-proBNP表达的影响

扫码查看
目的 观察加味来复汤联合常规疗法治疗慢性心力衰竭(CHF)急性加重期的临床疗效.方法 将100例患者随机分为两组各50例.对照组采用西医综合治疗措施,观察组在对照组的基础上采用加味来复汤辨证内服,每天1剂,连续治疗4周.比较治疗前后超声心动图参数;检测治疗前后心肌损伤生物标志物水平;进行治疗前后6分钟步行距离(6MWT)、阳虚血瘀证积分、NYHA心功能分级和静息心率评估;进行治疗前后Memo-rial 心力衰竭症状评估量表(MSAS-HF)和明尼苏达心衰生活质量量表(MLHFQ)评估;比较治疗后疾病总有效率.结果 治疗后,两组患者超声心动图参数[左室射血分数(LVEF)、每搏心搏量(SV)、每分钟心排血量(CO)和心脏指数(CI)]均升高(P<0.05),且观察组高于对照组(P<0.05);治疗后,两组患者N末端B型利钠肽原(NT-proBNP),采用酶联免疫吸附剂测定心脏肌钙蛋白Ⅰ(cTnⅠ)、心型脂肪酸结合蛋白(H-FABP)和半乳糖凝集素-3(GAL-3)水平下降(P<0.05),且观察组低于对照组(P<0.05).治疗后,两组患者MSAS-HF量表各个维度评分和总分降低(P<0.05),两组患者MLHFQ量表各个维度评分和总分降低(P<0.05),两组患者阳虚血瘀证各主要症状和总积分降低,且观察组以上各指标均低于对照组(P<0.05).治疗后两组6MWT增加(P<0.05),静息心率减少(P<0.05),且均以观察组为显著(P<0.05).观察组总有效率明显高于对照组(P<0.05).结论 加味来复汤联合常规疗法治疗CHF急性加重期患者,可保护心肌损伤,减轻心衰相关临床症状、体征及中医证候,改善心功能,提高患者的生活质量和运动耐力,临床疗效优于西医常规治疗效果.
Effects of Modified Laifu Decoction on Serum H-FABP,cTnⅠ,and NT-proBNP Expression in Patients with Acute Exacerbation of Chronic Heart Failure
Objective:To evaluate the clinical efficacy of modified Laifu Decoction combined with conventional therapy in the treatment of acute exacerbation of chronic heart failure(CHF).Methods:Totally 100 patients were randomly divided into the control group and observation group,with 50 cases in each group.The control group re-ceived comprehensive treatment with western medicine,while the observation group was given modified Laifu De-coction on the basis of the control group,one dose/day,and continuously for four weeks.Echocardiographic param-eters(LVEF,SV,CO and CI)were compared before and after treatment;myocardial injury biomarkers(NT-proB-NP,cTnⅠ,H-FABP and GAL-3)levels were measured before and after treatment;6-minute walk test distance(6 MWT),yang deficiency and blood stasis syndrome,NYHA functional classification and resting heart rate were as-sessed before and after treatment;MSAS-HF and MLHFQ were assessed before and after treatment;and the over-all response rate was compared after treatment.Results:After treatment,echocardiographic parameters(LVEF,SV,CO and CI)increased in both groups(P<0.05),and the observation group was higher than the control group(P<0.05);after treatment,NT-proBNP,cTnⅠ,H-FABP and GAL-3 levels decreased in both groups(P<0.05),and the observation group was lower than the control group(P<0.05).After treatment,the scores of all dimensions and to-tal score of MSAS-HF scale decreased in the two groups(P<0.05),the scores of all dimensions and total score of MLHFQ scale decreased in the two groups(P<0.05),the main symptoms and total scores of yang deficiency and blood stasis syndrome decreased in the two groups,and the above indicators in the observation group were lower than those in the control group(P<0.05).After treatment,6 MWT increased(P<0.05)and resting heart rate de-creased in both groups(P<0.05),and were observed to be significant(P<0.05).The total effective rate in the ob-servation group was significantly higher than that in the control group(P<0.05).Conclusion:The combination of modified Laifu Decoction and conventional therapy can protect myocardial injury,reduce clinical symptoms,signs and TCM syndromes related to heart failure,improve heart function,enhance the quality of life and exercise endur-ance in the acute exacerbation stage of CHF.The clinical efficacy is better than that of conventional western medi-cine treatment.

Chronic heart failureAcute exacerbation periodModified Laifu DecoctionYang deficiency and blood stasis syndromeQuality of lifeBiomarkers of myocardial injury

李想、李妍、岳宝霞

展开 >

山东省青岛市第八人民医院,山东 青岛 266000

慢性心力衰竭 急性加重期 加味来复汤 阳虚血瘀证 生活质量 心肌损伤生物标志物

山东省中医药科技项目

M-2023191T

2024

中国中医急症
中华中医药学会

中国中医急症

CSTPCD
影响因子:1.144
ISSN:1004-745X
年,卷(期):2024.33(6)
  • 17